References
- Yan Y, Liu J, Luo B, et al. The clinicopathological features of the pituitary adenoma and risk factors of recurrence. Asian J Surg. 2022;45(1):616–617.
- Alexander JM, Biller BM, Bikkal H, et al. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest. 1990;86(1):336–340.
- Herman V, Fagin J, Gonsky R, et al. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab. 1990;71(6):1427–1433.
- Picó A, Aranda-López I, Sesmillo G, et al. Recommendations on the pathological report of pituitary tumors. A consensus of experts of the Spanish Society of Endocrinology and Nutrition and the Spanish Society of Pathology. Rev Esp Patol. 2021;54:263–274.
- Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med. 2020;382(10):937–950.
- Snyder PJ. Clinical manifestations and diagnosis of gonadotroph and other clinically nonfunctioning pituitary adenomas. 2016:1–18. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-gonadotroph-and-other-clinically-nonfunctioning-pituitary-adenomas?source=search_result&search=pituitary+adenoma&selectedTitle=2∼150.
- Altuntaş SÇ, Evran M, Sert M, et al. Markers of metabolic syndrome in patients with pituitary adenoma: A case series of 303 patients. Horm Metab Res. 2019;51(11):709–713.
- Chin BM, Orlandi RR, Wiggins RH 3rd Evaluation of the sellar and parasellar regions. Magn Reson Imaging Clin N Am. 2012;20(3):515–543.
- Youmans Jr., Winn H Youmans neurological surgery. Philadelphia, PA: Saunders; 2011.
- Araujo-Castro M, Acitores Cancela A, Vior C, et al. Radiological knosp, Revised-Knosp, and Hardy–Wilson classifications for the prediction of surgical outcomes in the endoscopic endonasal surgery of pituitary adenomas: study of 228 cases. Front Oncol. 2022;11(January):1–13.
- Yuhan L, Zhiqun W, Jihui T, et al. Ki-67 labeling index and knosp classification of pituitary adenomas Ki-67 labeling index and knosp classification of pituitary adenomas. Br J Neurosurg. 2021;0(0):1–5.
- Esposito K, Chiodini P, Colao A, et al. Metabolic syndrome, and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012;35(11):2402–2411.
- Bhatt HB, Danak SU, Bratman REM. Metabolic Syndrome. In: Clinical Advisor, Ferri (ed). Elsevier (Ed.). 2022:978.e2-978.e10.
- Dabke K, Hendrick G, Devkota S. The gut microbiome and metabolic syndrome. J Clin Invest. 2019;129(10):4050–4057.
- Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D’Agostino RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91(8):2906–2912.
- Tortosa F, Webb SM. Novel aspects in histopathology of the pituitary gland. Endocrinol Diabet Nutr. 2017;64(3):152–161.
- Bashari WA, Senanayake R, Fernández-Pombo A, Gillett D, Koulouri O, Powlson AS, Matys T, Scoffings D, Cheow H, Mendichovszky I, Gurnell M. Modern imaging of pituitary adenomas. Best Pract Res Clin Endocrinol Metab. 2019;33(2):101278. pp. 1–19.
- Daly AF, Beckers A. The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am. 2020;49(3):347–355.
- Bonneville JF, Bonneville F, Cattin F. Magnetic resonance imaging of pituitary adenomas. Eur Radiol. 2005;15(3):543–548.
- Esposito D, Olsson DS, Ragnarsson O, et al. Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management. Pituitary. 2019;22(4):422–434.
- Andersen M, Glintborg D. Metabolic syndrome in hyperprolactinemia. Front Horm Res. 2018;49(Cvd):29–47.
- Takeuchi K, Nagatani T, Watanabe T, et al. A purely endoscopic and simultaneous transsphenoidal and transcranial keyhole approach for giant pituitary adenoma resection: a technical case report. NMC Case Rep J. 2015;3:101–105.
- Li M, Zhang J, Yang G, Zhang J, Han M, Zhang Y, Liu Y. Effects of anterior pituitary adenomas’ hormones on glucose metabolism and its clinical implications. Diabetes Metab Syndr Obes. 2023;16:409–424.
- Lucke-Wold B, Shawley S, Ingels JS, Stewart J, Misra R. A critical examination of the use of trained health coaches to decrease the metabolic syndrome for participants of a community-based diabetes prevention and management program. J Healthc Commun. 2016;1(4):38–57.